Cargando…
Variant-derived SARS-CoV-2 spike protein does not directly cause platelet activation or hypercoagulability
Thrombosis has been associated with severity and mortality in COVID-19. SARS-CoV-2 infects the host via its spike protein. However, direct effects of spike proteins from SARS-CoV-2 variants on platelet activity and coagulability have not been examined. An ethically approved ex vivo study was perform...
Autores principales: | Kusudo, Eriko, Murata, Yutaka, Kawamoto, Shuji, Egi, Moritoki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10198021/ https://www.ncbi.nlm.nih.gov/pubmed/37208552 http://dx.doi.org/10.1007/s10238-023-01091-4 |
Ejemplares similares
-
Effects of whole blood storage in a polyolefin blood bag on platelets for acute normovolemic hemodilution
por: Murata, Yutaka, et al.
Publicado: (2021) -
Use of argatroban in combination with nafamostat mesilate in open-heart surgery for a pediatric patient with heparin-induced thrombocytopenia type II: a case report
por: Kawamoto, Shuji, et al.
Publicado: (2020) -
Platelet activity and hypercoagulation in type 2 diabetes
por: Pretorius, Lesha, et al.
Publicado: (2018) -
SARS-CoV-2 and Plasma Hypercoagulability
por: Steadman, Elisabeth, et al.
Publicado: (2021) -
Rocuronium Has a Suppressive Effect on Platelet Function via the P2Y12 Receptor Pathway In Vitro That Is Not Reversed by Sugammadex
por: Murata, Yutaka, et al.
Publicado: (2020)